Literature DB >> 27488126

Walking towards personalized medicine in pulmonary rehabilitation: Comorbidities and COPD.

Rachael A Evans1.   

Abstract

Entities:  

Keywords:  COPD; Co-morbidities; Personalised Medicine; Pulmonary Rehabilitation

Mesh：

Year:  2016        PMID： 27488126      PMCID： PMC5720192          DOI： 10.1177/1479972316653532

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN： 1479-9723            Impact factor:   2.444


× No keyword cloud information.
  9 in total

1.  Objectively identified comorbidities in COPD: impact on pulmonary rehabilitation outcomes.

Authors:  Rafael Mesquita; Lowie E G W Vanfleteren; Frits M E Franssen; Janeli Sarv; Ziad Taib; Miriam T J Groenen; Swetlana Gaffron; Piet L B Bruijnzeel; Fabio Pitta; Emiel F M Wouters; Martijn A Spruit
Journal:  Eur Respir J       Date:  2015-06-25       Impact factor: 16.671

Review 2.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Jørgen Vestbo; Suzanne S Hurd; Alvar G Agustí; Paul W Jones; Claus Vogelmeier; Antonio Anzueto; Peter J Barnes; Leonardo M Fabbri; Fernando J Martinez; Masaharu Nishimura; Robert A Stockley; Don D Sin; Roberto Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  2012-08-09       Impact factor: 21.405

3.  Does body mass index influence the outcomes of a Waking-based pulmonary rehabilitation programme in COPD?

Authors:  Neil J Greening; Rachael A Evans; Johanna E A Williams; Ruth H Green; Sally J Singh; Michael C Steiner
Journal:  Chron Respir Dis       Date:  2012-03-13       Impact factor: 2.444

Review 4.  Mortality in COPD: Role of comorbidities.

Authors:  D D Sin; N R Anthonisen; J B Soriano; A G Agusti
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

5.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

6.  Randomised controlled trial of respiratory rehabilitation.

Authors:  R S Goldstein; E H Gort; D Stubbing; M A Avendano; G H Guyatt
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

7.  Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation.

Authors:  E Crisafulli; S Costi; F Luppi; G Cirelli; C Cilione; O Coletti; L M Fabbri; E M Clini
Journal:  Thorax       Date:  2008-01-18       Impact factor: 9.139

Review 8.  Systemic manifestations and comorbidities of COPD.

Authors:  P J Barnes; B R Celli
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

9.  Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.

Authors:  Lowie E G W Vanfleteren; Martijn A Spruit; Miriam Groenen; Swetlana Gaffron; Vanessa P M van Empel; Piet L B Bruijnzeel; Erica P A Rutten; Jos Op 't Roodt; Emiel F M Wouters; Frits M E Franssen
Journal:  Am J Respir Crit Care Med       Date:  2013-04-01       Impact factor: 21.405
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.